The N3A receptor, as modeled here by the UB researchers, may be silent under normal conditions, but can be reactivated through the unique site (in red) under acidic conditions, such as after a stroke or seizure.
Strokes, seizures, traumatic brain injury and schizophrenia: these conditions can cause persistent, widespread acidity around neurons in the brain. But exactly how that acidity affects brain function isn’t well understood. University at Buffalo researchers have begun to unravel some of the puzzle. They found that an elusive brain receptor may play an important role in the death of neurons from neurological diseases.
The UB researchers study a family of brain receptors that are critical to learning and memory, called NMDA (N-methyl-D-aspartate) receptors. One of these receptors N3A functions through a different mechanism than all other NMDA receptors.
“We found that in contrast to all other NMDA receptors, acidity can reactivate dormant N3A receptors,” said Gabriela K. Popescu, PhD. “This insight led us to hypothesize that N3A receptors are silent in normal conditions, which may explain why other researchers have failed to observe them previously.”
Popescu and Kirstie A. When N3A receptors were exposed to acidic conditions, as occurs in brain disorders such as stroke or epilepsy, they reactivate, causing neurons to become more sensitive to the neurotransmitter glutamate, which can, under certain circumstances, kill them.
The research was done in cell culture with recombinant receptors. Finding ways to prevent acidification or the reactivation of N3A receptors may prevent brain damage from strokes or seizures. N3A proteins appear to be more abundant in brains of people with schizophrenia. “This is in line with our findings, since schizophrenia, a disease associated with high acidity in the brain, causes brains to shrink,” Popescu noted.
Electrical currents passed by N3A receptors can excite cells in response to acidity, which makes them different from all other NMDA receptors. The researchers have identified the site on the receptor where acidity acts to reactivate these receptors, a different location from the site where acidity acts to inhibit all other NMDA receptors. “This site is new and unique and thus can be used to make drugs that are very specific to the N3A receptor,” said Popescu. http://www.buffalo.edu/news/releases/2016/04/073.html
Recent Comments